Veterinary Medicines Directorate

References and list of enforcement notices and prosecutions which involved illegal activity with animal medicines in the last year.

This UK VARSS report provides the details of UK veterinary antibiotic resistance and sales surveillance.

Residues of veterinary medicines in food 2026 surveillance results, a rolling summary.

Reporting against VMD published standards up to 31 March 2027.

Benefit-Risk Submission Report (BRSR) and Pharmacovigilance Sales Submission (PSS) templates and guidance for completion of BRSRs, PSSs and signal notifications.

Explanation of what Pharmacovigilance means and who is responsible. These documents must be read with the Implementation Explainer at VMD Information Hub.

Monthly reporting against service standards for answering general enquiries.

Annual report and accounts for the financial year April 2025 to March 2026.

Privacy notice regarding personal data processed by the VMD.

Residues of veterinary medicines in food 2025 surveillance results, a rolling summary.

We are seeking views on proposals to revise the charges paid by businesses in the NRCP (National Residues Control Programme).

Reporting against VMD published standards up to 31 March 2026.

All national applications will be processed on one of six timetables that vary in length depending on the complexity and nature of the application under assessment.

Results of in-depth assessment of reports of death, arthritis and human exposure following administration of Librela in dogs in the United Kingdom.

This UK VARSS report provides the details of UK veterinary antibiotic resistance and sales surveillance.

Sales data from Marketing Authorisation Holders for UK authorised veterinary medicines and UK authorised specified feed additives containing anticoccidials (coccidiostats), antiprotozoals and antifungals.

This Statement of Intent sets out a strategic framework for future cross-sector action to address issues concerning veterinary vaccine availability.

How we comply with the Regulators’ Code requirements.

The Pharmaceuticals in the Environment Group (PiE) have set out a roadmap of activities to address the levels of fipronil and imidacloprid detected in UK waterways.

Annual report and accounts for the financial year April 2024 to March 2025.

The Government’s approach to safeguarding the continued supply of veterinary medicines in Northern Ireland from 1 January 2026.

Residues of veterinary medicines in food 2024 surveillance results, a rolling summary.

Reporting against VMD published standards up to 31 March 2025.

Vaccination of birds against high pathogenicity avian influenza joint statement from the avian influenza vaccination taskforce.

Marketing Authorisations Veterinary Information Service (MAVIS) Hub edition 133.

This document sets out Defra group’s equality objectives for 2024 to 2026.

Marketing Authorisations Veterinary Information Service (MAVIS) Hub edition 132.

Document for the Veterinary Medicines Directorate annual report and accounts 2023 to 2024.

This UK VARSS report provides the details of UK veterinary antibiotic resistance and sales surveillance.

Summary of product characteristics for BLUEVAC-3 BTV-3 vaccine in the UK

Summary of product characteristics for Bultavo-3 BTV-3 vaccine in the UK

Summary of product characteristics for Syvazul BTV-3 vaccine in the UK

We are seeking views on proposals to revise the charges paid by businesses in the National Residues Control Programme (NRCP).

Marketing Authorisations Information Service (MAVIS) Hub edition 131

Marketing Authorisations Information Service (MAVIS) Hub edition 130

Residues of veterinary medicines in food 2023 surveillance results, a rolling summary.

Seeking views on changes to the law on veterinary medicines.

Marketing Authorisations Information Service (MAVIS) Hub edition 129

The third publication of the One Health Report brings together antibiotic resistance and consumption data from humans, animals, food, and the environment.

Marketing Authorisations Information Service (MAVIS) Hub edition 128

Document for the Veterinary Medicines Directorate annual report and accounts 2022 to 2023.

Marketing Authorisations Information Service (MAVIS) Hub edition 127.

Proposals set out to update the Veterinary Medicines Regulations for batch testing and batch releasing of imported veterinary medicines, as they apply in GB.

Marketing Authorisations Information Service (MAVIS) Hub edition 126.

Marketing Authorisations Information Service (MAVIS) Hub edition 125.

Marketing Authorisations Information Service (MAVIS) Hub edition 124.

Document for the Veterinary Medicines Directorate annual report and accounts 2021 to 2022.

Marketing Authorisations Information Service (MAVIS) Hub edition 123.

Marketing Authorisations Information Service (MAVIS) Hub edition 122.

Marketing Authorisations Information Service (MAVIS) Hub edition 121.

Marketing Authorisations Information Service (MAVIS) Hub edition 120

Marketing Authorisations Information Service (MAVIS) Hub edition 119

Marketing Authorisations Information Service (MAVIS) Hub edition 118

Marketing Authorisations Information Service (MAVIS) Hub edition 117

Marketing Authorisations Information Service (MAVIS) Hub edition 116

Marketing Authorisations Information Service (MAVIS) Hub edition 115

Marketing Authorisations Information Service (MAVIS) Hub edition 114

Marketing Authorisations Information Service (MAVIS) Hub edition 113